Investor Frequently Asked Questions
When was Systems Xcellence (SXC) founded?
SXC was founded in 1993.
Where is SXC’s corporate headquarters?
SXC’s corporate headquarters is located in Lisle, Illinois, USA.
Lisle, Illinois
2441 Warrenville Road,
Suite 610
Lisle, IL, 60532-3642
T: (630) 577-3100
(800) 282-3232
F: (630) 577-3101
Pharmacy Help Desk: 800-325-1810
How many employees does SXC have?
SXC has more than 300 employees across North America.
Who are SXC’s executive officers and directors?
Biographies of SXC’s executive officers and directors can be found here.
How long has Chairman Gordon Glenn been associated with SXC?
Mr. Glenn joined SXC in June 1998, bringing 27 years of experience in the software products, systems integration and processing industries.
What is SXC’s growth strategy?
SXC’s objective is to enhance its position as a leading provider of healthcare information technology solutions and pharmacy benefit management services to participants in the pharmaceutical supply chain in the US and Canada.
SXC’s primary growth strategies are to:
-
Expand the breadth of InformedRx services for health plans, self-insured employers and government agencies that sponsor pharmacy benefit plans.
-
Provide additional InformedRx services to its existing payer customer base.
-
Focus provider sales activities on the small to mid-size retail chain marketplace.
-
Continue to lead through product innovation built on superior technology.
-
Further broaden its markets and offerings by pursuing strategic acquisitions.
Who are some of SXC’s key customers?
SXC’s client base is composed of payers, providers and other participants in the pharmaceutical supply chain in the United States and Canada. [NTD Say North America] or just US]
-
Payer customers include over 70 managed care organizations (MCOs), Blue Cross/Blue Shield (BCBS) organizations, government agencies, employers and intermediaries such as pharmacy benefit management organizations (PBMs).
-
Provider customers include over 1,200 independent, regional chain, institutional and mail-order pharmacies.
What are some of SXC’s key strengths?
SXC’s competitive strengths include:
-
Flexible service offerings and customer choice. Not only does SXC provide innovative PBM services, but it also delivers these services on an à la carte basis with transparent pricing. This unique feature is a key differentiator between SXC and its competitors.
-
Leading technology. SXC believes it has one of the most comprehensive claims processing and pharmacy practice management platforms in the market. The Company’s technology is built with flexible, database-driven rule sets and has broad functionality adaptable to most customers’ needs.
-
Measurable cost savings for our customers. SXC provides its customers with increased control over drug dispensing activities and benefit programs. The Company’s transparent pricing models and flexible product offerings are designed to deliver measurable cost savings to its customers.
-
Strong customer relationships and domain expertise. Through SXC’s experience developing and supporting pharmacy solutions for millions of lives, it has become an industry leader in establishing best practices and developing strong customer relationships.
-
Experienced and proven management team. SXC has assembled a senior management team of industry veterans with a proven track record for profitable growth both organically and through acquisitions.
Where does SXC trade?
When did SXC become a public company?
SXC went public on the TSX in 1995 and on the NASDAQ in 2006.
How many SXC shares are issued and outstanding?
Approximately 20.17 million.
When is SXC’s year-end?
December 31.
| Quarter | Final Filing Date |
| Q1 ends March 31 | May 15 |
| Q2 ends June 30 | August 14 |
| Q3 ends September 30 | November 14 |
| Q4 ends December 31 | March 31 |
How can I purchase SXC’s shares in common stock?
Shares of common stock can be purchased through the brokerage firm of your choice or through any financial institution that provides brokerage services.
Does SXC have a dividend reinvestment program (DRIP) plan or a direct stock purchase plan?
SXC does not issue dividends on common stock or have a direct stock purchase plan. Instead, SXC has opted to reinvest profits into its operations. SXC stock can only be purchased through a registered broker, as SXC does not buy or sell stock directly.
Why can’t I find SXC’s 10-Ks and 10-Qs on EDGAR?
SXC is listed on NASDAQ as a foreign private issuer. As such, it is required to file Forms 40-F and 6-K, instead of Forms 10-K, 10-Q and 8-K. Forms 40-F and 6-K serve as a wraparound for the company's Canadian public reports. Canadian regulatory filings can be found on www.sedar.com, the Canadian equivalent of EDGAR.
Who is SXC’s transfer agent?
SXC’s transfer agent is CIBC Mellon Trust Company. Please direct all share certificate questions to:
CIBC Mellon Trust Company
320 Bay Street
P.O. Box 1
Toronto, ON, M5J 2T9
Tel: 416-643-5500 or 1-800-387-0825
As a shareholder of SXC, how do I change my address on your mailing list?
To change your address on our mailing list, contact your financial planner or our transfer agent, CIBC Mellon Trust Company.
Who is SXC’s auditor?
KPMG LLP
Suite 3300, Commerce Court West
199 Bay Street
Toronto, ON, M5L 1B2
Telephone: (416) 777-8500
Telefax: (416) 777-8818
How do I get added to SXC’s shareholder database to receive press releases and corporate announcements via email? How can I request an investor kit?
Please contact:
Dave Mason
Investor Relations – The Equicom Group Inc.
Tel: (416) 815-0700 x237
Fax: (416) 815-0080
dmason@equicomgroup.com
Or contact our Investor Relations team via e-mail at investors@sxc.com
